C3orf39 Activators are a niche category within the realm of biochemical research, targeting the C3orf39 gene product, a protein encoded by a gene located on the third chromosome. This protein is part of a complex network of intracellular components that contribute to the fundamental operations within a cell, including but not limited to, regulatory processes, signaling pathways, and structural integrity. The activators designed to target C3orf39 are synthesized through meticulous chemical engineering, aiming to enhance or modulate the activity of the C3orf39 protein. These compounds are characterized by their specificity in binding to the C3orf39 protein, influencing its functional state and consequently its role in cellular activities. The development of these activators involves an in-depth understanding of the protein's structure, its active sites, and the conformational changes that govern its activity within the cellular environment.
The exploration into C3orf39 Activators encompasses a multidisciplinary approach, leveraging advanced techniques in molecular biology, chemistry, and computational modeling to understand the interaction between these compounds and the C3orf39 protein. Researchers utilize a variety of analytical methods, such as high-throughput screening, X-ray crystallography, and nuclear magnetic resonance (NMR) spectroscopy, to identify potential activators and elucidate their mechanisms of action at the molecular level. This research sheds light on the intricate dynamics of protein-ligand interactions, offering insights into the fundamental principles that govern cellular function. By focusing on the modulation of the C3orf39 protein's activity, scientists aim to unravel the complex biological processes in which this protein is involved, contributing to a broader understanding of cellular regulation and protein function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Manganese(II) chloride beads | 7773-01-5 | sc-252989 sc-252989A | 100 g 500 g | $19.00 $31.00 | ||
Manganese ions are known cofactors for some glycosyltransferases and could potentially activate POMGNT2 by stabilizing its active form. | ||||||
N-Acetyl-D-glucosamine | 7512-17-6 | sc-286377 sc-286377B sc-286377A | 50 g 100 g 250 g | $94.00 $162.00 $306.00 | 1 | |
As a building block of glycan structures, N-Acetylglucosamine might impact POMGNT2 activity by altering glycan biosynthesis pathways. | ||||||
NAD+, Free Acid | 53-84-9 | sc-208084B sc-208084 sc-208084A sc-208084C sc-208084D sc-208084E sc-208084F | 1 g 5 g 10 g 25 g 100 g 1 kg 5 kg | $57.00 $191.00 $302.00 $450.00 $1800.00 $3570.00 $10710.00 | 4 | |
NAD+ is a coenzyme in redox reactions and might indirectly affect POMGNT2 through cellular redox states and metabolic regulation. | ||||||
L-(−)-Fucose | 2438-80-4 | sc-221792 sc-221792A sc-221792B sc-221792C | 10 mg 5 g 50 g 100 g | $31.00 $153.00 $454.00 $840.00 | ||
Fucose is a component of some glycoproteins and its availability could influence glycosylation patterns, potentially impacting POMGNT2 activity. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation and could indirectly affect POMGNT2 by altering the cellular glycosylation machinery. | ||||||
Swainsonine | 72741-87-8 | sc-201362 sc-201362C sc-201362A sc-201362D sc-201362B | 1 mg 2 mg 5 mg 10 mg 25 mg | $138.00 $251.00 $631.00 $815.00 $1832.00 | 6 | |
Swainsonine inhibits mannosidase II and could lead to altered glycosylation patterns that affect POMGNT2 indirectly. | ||||||
Castanospermine | 79831-76-8 | sc-201358 sc-201358A | 100 mg 500 mg | $184.00 $632.00 | 10 | |
As an inhibitor of glucosidases, castanospermine might change glycan processing and potentially affect POMGNT2 activity indirectly. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts Golgi apparatus function, which could lead to changes in glycosylation pathways involving POMGNT2. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophores can change intracellular calcium levels, which might influence POMGNT2 activity by affecting its regulatory mechanisms. | ||||||